It targets neurodegenerative diseases, autism, ADHD, dementia, age-related cognitive decline, psychiatric disorders, and brain aging.

Brain entropy is a measure of the complexity and variability of brain activity. Higher entropy reflects greater cognitive flexibility, creativity, and consciousness.

LA203 increases brain entropy, as shown by enhanced complexity in brain signals, leading to improved brain activity and function.

LA203 is based on negentropy-driven self-assembly of aperiodic crystals that convey bio-information to the brain.

It contains two types of crystals: one made from poly-lysine and glutamic acid, and another from a sulfated polysaccharide with amino acids and cyanocobalamin.

The ingredients are freeze-dried in a CO₂-enriched hydrophilic medium and then formed into capsules under high vacuum to preserve structure and potency.

Using transcranial ultrasonography, fNIRS (functional near-infrared spectroscopy), EEG, and a cognitive assessment questionnaire.

fNIRS measures oxygenation and blood volume in the brain’s prefrontal cortex, showing increased activity after LA203 intake.

It’s a brain region responsible for planning, decision-making, memory, social cognition, and self-awareness—functions enhanced by LA203.

Some subjects reported cognitive and physical improvements within 7–10 days of taking the product.

Yes, users and study results indicated improved short- and long-term memory as part of cognitive enhancement.

By improving brain entropy and regulating the parasympathetic nervous system (PNS), it helps manage symptoms related to stress and focus.